AbbVie Inc (ABBV) Stock Price Today
Aura AI Summary
Key Stats
- $496.77BMarket Cap
- 5,493,421Volume
- HealthSector
- $281.0452W High
- $197.3852W Low
- 93 DaysTypical Hold Time
- $561.03BEnterprise Value
- 2.46%Div Yield
- 85% Sell | 15% BuyTrading Activity
Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $281.04, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Most Recent News
WisdomTree's $1.2B tokenized money market fund receives top AAA rating from Particula.
Particula has assigned a AAA-rating to WisdomTree Treasury Money Market Digital Fund (WTGXX), a $1.2 billion tokenized money market fund. The fund invests in short-term U.S. Treasury securities and government money market funds, aiming to preserve ca...

AlphaPepe presale hits 12,500 holders ahead of major exchange reveal; Bitcoin eyes $100,000 target.
AlphaPepe's cryptocurrency presale has surpassed 12,500 holders and raised nearly $3 million before its first public exchange listing, signaling strong community growth. More than 100 new holders join daily, with a fifth centralized exchange (CEX) pa...

Syndax shares drop over 11% after axatilimab fails Phase 2 trial in lung disease IPF
Syndax Pharmaceuticals' stock fell more than 11% after its drug axatilimab failed to meet the primary endpoint in a Phase 2 trial for idiopathic pulmonary fibrosis (IPF). The trial showed no benefit in lung function decline, leading Syndax to halt fu...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.